1-10 of 10
Eckhard Thiel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune escape mechanisms in patients with AML receiving WT1 peptide vaccination

Ulrich Keilholz, Antonia Busse, Sebastian Ochsenreither, Anne Letsch, Carmen Scheibenbogen, Wolfgang Blau, Wolfgang Blau, Eckhard Thiel
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15_Supplement): A25.
Published: 15 August 2014
View article titled, Immune escape mechanisms in patients with AML receiving WT1 peptide vaccination
Journal Articles

CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients

Lars Fischer, Agnieszka Korfel, Sebastian Pfeiffer, Philipp Kiewe, Hans-Dieter Volk, Hüsniye Cakiroglu, Thomas Widmann, Eckhard Thiel
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 5968–5973.
https://doi.org/10.1158/1078-0432.CCR-09-0108
Published: 30 September 2009
View article titled, CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
Open the PDF for CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients in another window
Journal Articles

Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma

Ronny Schuster, Nikolaos E. Bechrakis, Andrea Stroux, Antonia Busse, Alexander Schmittel, Carmen Scheibenbogen, Eckhard Thiel, Michael H. Foerster, Ulrich Keilholz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (4): 1171–1178.
https://doi.org/10.1158/1078-0432.CCR-06-2329
Published: 22 February 2007
View article titled, Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma
Open the PDF for Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma in another window
Journal Articles

Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1

Anne Marie Asemissen, Ulrich Keilholz, Stefan Tenzer, Margret Müller, Steffen Walter, Stefan Stevanovic, Hansjörg Schild, Anne Letsch, Eckhard Thiel, Hans-Georg Rammensee, Carmen Scheibenbogen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7476–7482.
https://doi.org/10.1158/1078-0432.CCR-06-1337
Published: 22 December 2006
View article titled, Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1
Open the PDF for Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1 in another window
Journal Articles

Clinical and Immunologic Responses to Active Specific Cancer Vaccines in Human Colorectal Cancer

Dirk Nagorsen, Eckhard Thiel
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (10): 3064–3069.
https://doi.org/10.1158/1078-0432.CCR-05-2788
Published: 17 May 2006
View article titled, Clinical and Immunologic Responses to Active Specific Cancer Vaccines in Human Colorectal Cancer
Open the PDF for Clinical and Immunologic Responses to Active Specific Cancer Vaccines in Human Colorectal Cancer in another window
Journal Articles

Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer

Philipp Kiewe, Stephan Hasmüller, Steffen Kahlert, Maja Heinrigs, Brigitte Rack, Alexander Marmé, Agnieszka Korfel, Michael Jäger, Horst Lindhofer, Harald Sommer, Eckhard Thiel, Michael Untch
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (10): 3085–3091.
https://doi.org/10.1158/1078-0432.CCR-05-2436
Published: 17 May 2006
View article titled, Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer
Open the PDF for Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer in another window
Journal Articles

Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma In vivo: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104)

Anne Marie Asemissen, Carmen Scheibenbogen, Anne Letsch, Kristoffer Hellstrand, Fredrik Thorén, Kurt Gehlsen, Alexander Schmittel, Eckhard Thiel, Ulrich Keilholz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 290–297.
https://doi.org/10.1158/1078-0432.290.11.1
Published: 21 January 2005
View article titled, Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma <em>In vivo</em>: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104)
Open the PDF for Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma <em>In vivo</em>: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104) in another window
Journal Articles

Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction

Ulrich Keilholz, Petra Goldin-Lang, Nikolaos E. Bechrakis, Nicole Max, Anne Letsch, Alexander Schmittel, Carmen Scheibenbogen, Karin Heufelder, Alexander Eggermont, Eckhard Thiel
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (5): 1605–1612.
https://doi.org/10.1158/1078-0432.CCR-0610-3
Published: 10 March 2004
View article titled, Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Open the PDF for Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction in another window
Journal Articles

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma: Results from a Phase II Multicenter Study

Miklos Pless, Karim Belhadj, Hans D. Menssen, Wolfgang Kern, Bertrand Coiffier, Jürgen Wolf, Richard Herrmann, Eckhard Thiel, Doug Bootle, Ivo Sklenar, Christian Müller, Les Choi, Carl Porter, Renaud Capdeville
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1299–1305.
https://doi.org/10.1158/1078-0432.CCR-0977-03
Published: 20 February 2004
View article titled, Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma: <subtitle>Results from a Phase II Multicenter Study</subtitle>
Open the PDF for Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma: <subtitle>Results from a Phase II Multicenter Study</subtitle> in another window
Journal Articles

Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy

Michael Mohr, Eva Hilgenfeld, Thomas Fietz, Berthold Hoppe, Michael Koenigsmann, Marianne Hoffmann, Wolfgang U. Knauf, Uwe Cassens, Walter Sibrowski, Joachim Kienast, Eckhard Thiel, Wolfgang E. Berdel
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (5): 1035–1040.
Published: 01 May 1999
View article titled, Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy
Open the PDF for Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy in another window